Aronex Pharmaceuticals, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Aronex Pharmaceuticals, Inc..The latest application filed is for "liposomal nystatin treatment of fungal infection".

Company Profile

0.10.3

Aronex Pharmaceuticals, Inc. - Lexington MA
Aronex Pharmaceuticals, Inc. -
Aronex Pharmaceuticals, Inc. - The Woodlands TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Oligonucleotide inhibitors of bcl-xL Grant 7,074,769 - Stein , et al. July 11, 2	2006-07-11
Liposomal nystatin treatment of fungal infection App 20020127273 - Walsh, Thomas	2002-09-12
Liposomal retinoid therapy in hormone refractory prostate cancer App 20020076434 - Williams, Anthony H.	2002-06-20
Guanosine-rich oligonucleotide integrase inhibitors Grant 6,355,785 - Rando , et al. March 12, 2	2002-03-12
Combined interferon alfa and lipsosmal-encapsulated all-trans retinoic acid, including preparation and use App 20020001615 - Nanus, David	2002-01-03
Anti-viral guanosine-rich oligonucleotides Grant 6,184,369 - Rando , et al. February 6, 2	2001-02-06
Liposomal-polyene preliposomal powder and method for its preparation Grant 5,965,158 - Link , et al. October 12, 1	1999-10-12
Liposomal-polyene preliposomal powder and method for its preparation Grant 5,830,498 - Lenk , et al. November 3, 1	1998-11-03
Formulation and use of carotenoids in treatment of cancer Grant 5,811,119 - Mehta , et al. September 22, 1	1998-09-22
Cationic lipid acid salt of 3beta[N- (N', N'-dimethylaminoethane) - carbamoyl]cholestrol and halogenated solvent-free preliposomal lyophilate thereof Grant 5,753,262 - Wyse , et al. May 19, 1	1998-05-19
Amphipathic nucleic acid transporter Grant 5,614,503 - Chaudhary , et al. March 25, 1	1997-03-25
Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof Grant 5,587,458 - King , et al. Dec	1996-12-24
Anti-viral guanosine-rich oligonucleotides Grant 5,567,604 - Rando , et al. October 22, 1	1996-10-22

Company Registrations

SEC

0000854691

ARONEX PHARMACEUTICALS INC of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.